- Executives from Predictmedix AI (CSE:PMED), a Canadian healthcare AI stock, will be departing for India this weekend to meet with institutional investors and government officials to expand market share
- The company provides rapid health screening and remote patient care solutions powered by proprietary artificial intelligence
- Its flagship Safe Entry Station can detect symptoms of infectious diseases as well as signs of impairment
- Predictmedix AI stock (CSE:PMED) is up by 100 per cent over the past year
Executives from Predictmedix AI (CSE:PMED), a Canadian healthcare AI stock, will be departing for India this weekend to meet with institutional investors and government officials to expand market share.
With visas now granted, the company is keen to “ensure seamless integration and scalable deployment of Predictmedix’s cutting-edge contactless AI solutions,” according to a statement released Wednesday. These solutions include:
- The Safe Entry Station, a non-invasive, no-contact, walk-through solution to detect symptoms of infectious diseases before they have a chance to spread
- The solution’s multispectral recognition technologies and AI models can also non-invasively screen for drug and alcohol impairment
- Mobilewellbeing, a wearable-based vital sign monitoring system backed by AI models that can recommend treatment and connect with a clinician’s patient management platform
“Our visit to India holds immense importance for us, as we look forward to collaborating with institutional partners and government officials to bring our transformative AI solutions to a wider audience,” Dr. Rahul Kushwah, COO of Predictmedix AI, said in the statement.
“By ensuring seamless integration and scalable deployment, we aim to make a significant positive impact on healthcare and various other sectors in India. We believe that this collaboration will pave the way for a future where AI-driven technologies enhance efficiency, safety and the overall well-being of the nation,” he added.
Predictmedix AI provides rapid health screening and remote patient care solutions powered by proprietary artificial intelligence.
Predictmedix AI stock (CSE:PMED) last traded at $0.10 per share. The stock is up by 100 per cent over the past year.
Join the discussion: Find out what everybody’s saying about this Canadian healthcare AI stock on the Predictmedix AI Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
